Wales Medicines Strategy Group
From Kidney Cancer Resource
Contents |
Overview
VALE OF GLAMORGAN – A spokesperson said, “The All Wales Medicines Strategy Group (AWMSG) will take into account the NICE future work programme, including the Single Track Assessment (STA) process, when considering whether a product will be appraised.
“(AWMSG) will not normally consider appraising a product if NICE intends to publish its final appraisal of the same product within an 18 month period.
“(AWMSG) can issue guidance on drugs which have yet to be Nice-d. Once Nice guidance is received, that supercedes the (AWMSG) guidance.
“In the absence of (AWMSG) or NICE guidance individual prescribers should exercise their clinical judgment unless there is evidence not to do so in the light of particular circumstances of an individual patient.”
References
Disclaimer
Kidney Cancer Resource (KCR) is not influenced by sponsors. The information contained herein is not intended as a substitute for the advice of an appropriately qualified and licensed physician or other licensed health care provider. The information provided here is for educational and information purposes only. Early accurate Diagnosis (Dx.) saves lives. Please check with a physician if you suspect you are ill, never ignore Symptoms. To help your health care specialist make an accurate Diagnosis please keep notes of dates, times and details of your Symptoms. We are not offering medical advice nor do we consider links, individuals or articles accessed through this site to be offering medical advice.
E&OE - Errors & Omissions Excepted
As much of the information posted on this Web Site for peoples convenience is of a medical or technical nature, and may be a matter of life or death the E&OE is a Disclaimer showing that to the best of our ability information is accurate and correctly written or transcribed. Before acting on information on this site you are responsible for checking it with your relevant medical team. We can not be held responsible for any Errors & Omissions made; nor for information on links and articles provided in good faith.
